Statin Use and Risk of Cataract Response to Letter
J Cardiovasc Pharmacol Ther
.
2016 Mar;21(2):223.
doi: 10.1177/1074248415591701.
Epub 2015 Jun 17.
Authors
John B Kostis
1
,
Jeanne M Dobrzynski
2
Affiliations
1
Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA kostis@rwjms.rutgers.edu.
2
Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
PMID:
26085336
DOI:
10.1177/1074248415591701
No abstract available
Publication types
Letter
Comment
MeSH terms
Animals
Cataract / diagnosis*
Cataract / prevention & control*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors